The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice
Open accessAbstract
We have reported previously (Michikawa, M., Fan, Q.-W., Isobe, I., and Yanagisawa, K. (2000) J. Neurochem. 74, 1008-1016) that exogenously added recombinant human apolipoprotein E (apoE) promotes cholesterol release in an isoform-dependent manner. However, the molecular mechanism underlying this isoform-dependent promotion of cholesterol release remains undetermined. In this study, we demonstrate that the cholesterol release is mediated by endogenously synthesized and secreted apoE isoforms and clarify the mechanism underlying this apoE isoform-dependent cholesterol release using cultured astrocytes prepared from human apoE3 and apoE4 knock-in mice. Cholesterol and phospholipids were released into the culture media, resulting in the generation of two types of high density lipoprotein (HDL)-like particles; one was associated with apoE and the other with apoJ. The amount of cholesterol released into the culture media from the apoE3-expressing astrocytes was approximately 2.5-fold greater than that from apoE4-expressing astrocytes. In contrast, the amount of apoE3 released in association with the HDL-like particles was similar to that of apoE4, and the sizes of the HDL-like particles released from apoE3- and apoE4-expressing astrocytes were similar. The molar ratios of cholesterol to apoE in the HDL fraction of the culture media of apoE3- and apoE4-expressing astrocytes were 250 +/- 6.0 and 119 +/- 5.1, respectively. These data indicate that apoE3 has an ability to generate similarly sized lipid particles with less number of apoE molecules than apoE4, suggesting that apoE3-expressing astrocytes can supply more cholesterol to neurons than apoE4-expressing astrocytes. These findings provide a new insight into the issue concerning the putative alteration of apoE-related cholesterol metabolism in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the central nervous system (CNS), apoE is mainly secreted by astrocytes, with different isoforms playing distinct roles in lipid metabolism and nervous system homeostasis [11, 12].”
From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies identified APOE-isoform specific effects on cholesterol flux and APOE levels in rodent brain cells and human periphery (Gong et al., 2002; Huang et al., 1995; Michikawa et al., 2000).”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Gong et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“cholesterol release is reduced in primary glial cultures from apoE-TR mice expressing apoE4 compared with glial cells expressing apoE3 (35,73).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [73]
The cited source says what the claim attributes to it.
In the citing paper
“apoE4 proteins are poorly lipidated and display an impaired capacity in lipid transport when compared to apoE3 proteins”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Gong et al 2002
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While APOE mRNA levels were unchanged in mouse (Gong et al., 2002)”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Gong et al., 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,177
Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868
Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 860
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., & Weisgraber, K. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47945-8 · Cited by 714
Flagged first, then by citations
Research works printed but not linked: 2
- Gong, 2002, J. Neurosci. Res.
- Fan, 2001, J. Am. Aging Assoc., 24, 1
Cited by
Sorted by citations
Items 101–200 of 213
Yi, D., Lee, D. Y., Sohn, B. K., Choe, Y. M., Seo, E. H., Byun, M. S., & Woo, J. I. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.12.173 · Cited by 42
Abdelhamid, M., Jung, C., Zhou, C., Abdullah, M., Nakano, M., Wakabayashi, H., Abe, F., & Michikawa, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191181 · Cited by 41
Self-citationSterols in the central nervous system
Mulder, M. T. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832182da · Cited by 37
APOEgene and neuropsychiatric disorders and endophenotypes: A comprehensive review
Forero, D. A., López‐León, S., González‐Giraldo, Y., Dries, D. R., Pereira‐Morales, A. J., Jiménez, K. M., & Franco‐Restrepo, J. E. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32516 · Cited by 38
Balancing cholesterol in the brain: from synthesis to disposal
Qian, L., Chai, A. B., Gelissen, I. C., & Brown, A. J. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00015 · Cited by 31
Jablonski, A. M., Warren, L., Usenovic, M., Zhou, H. H., Sugam, J. A., Parmentier‐Batteur, S., & Voleti, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-82901-1 · Cited by 38
APOE expression and secretion are modulated by mitochondrial dysfunction
Wynne, M. E., Ogunbona, O., Lane, A. R., Gokhale, A., Zlatic, S. A., Xu, C., Wen, Z., Duong, D. M., Rayaprolu, S., Ivanova, A., et al. (2023) · eLife · doi:10.7554/elife.85779 · Cited by 35
Peripheral cholesterol metabolic disorders and Alzheimer s disease
Maria, D. L. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/368 · Cited by 35
Jansen, P. J., Lütjohann, D., Thelen, K., von Bergmann, K., LEUVEN, F. V., Ramaekers, F. C. S., & Monique, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1150 · Cited by 36
Regulation of hippocampal cholesterol metabolism by apoE and environmental stimulation
Levi, O., Lütjohann, D., Devir, A., Von Bergmann, K., Hartmann, T., & Michaelson, D. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03441.x · Cited by 29
APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage
Raffeld, M. R., Biffi, A., Battey, T. W. K., Ayres, A. M., Viswanathan, A., Greenberg, S. M., Rosand, J. M., & Anderson, C. D. (2015) · Neurology · doi:10.1212/wnl.0000000000001790 · Cited by 32
H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment
Ali-Rahmani, F. G., Grigson, P. S., Lee, S. Y., Neely, E. B., Connor, J. R., & Schengrund, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.014 · Cited by 32
Abnormal gene expression in cerebellum of Npc1−/− mice during postnatal development
Liao, G., Wen, Z., Irizarry, K. J. L., Huang, Y. S., Mitsouras, K., Darmani, M., Leon, T. L., Shi, L. M., & Bi, X. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.019 · Cited by 31
Matsuo, M., Campenot, R. B., Vance, D. E., Ueda, K., & Vance, J. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.10.004 · Cited by 31
Suon, S., Zhao, J. J., Villarreal, S. A., Anumula, N., Liu, M., Carangia, L. M., Renger, J. J., & Zerbinatti, C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-44 · Cited by 31
Michikawa, M. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00681.x · Cited by 29
Self-citationModel Membranes and Their Interactions with Native and Artificial Lipoproteins
Waldie, S. (2020) · doi:10.24834/isbn.9789178771325 · Cited by 28
Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice
Rijpma, A., Jansen, D., Arnoldussen, I. A. C., Fang, X. T., Wiesmann, M., Mutsaers, M. P. C., Dederen, P. J. W. C., Janssen, C. I. F., & Kiliaan, A. J. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/531326 · Cited by 32
Nakato, M., Matsuo, M., Kono, N., Arita, M., Arai, H., Ogawa, J., Kioka, N., & Ueda, K. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058164 · Cited by 26
Metabolic reprogramming: a new option for the treatment of spinal cord injury
Chen, J., Chen, J., Yu, C., Xia, K., Yang, B., Wang, R., Li, Y., Shi, K., Zhang, Y., Xu, H., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01604 · Cited by 25
Axl receptor tyrosine kinase is a regulator of apolipoprotein E
Zhao, W., Fan, J., Kulic, I., Koh, C., Clark, A., Meuller, J., Engkvist, O., Barichievy, S., Raynoschek, C., Hicks, R., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00609-1 · Cited by 25
Patients with Alzheimer’s Disease May Be Particularly Susceptible to Adverse Effects of Statins
Algotsson, A., & Winblad, B. G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076342 · Cited by 25
Niemann-Pick Type C1 deficiency in microglia does not cause neuron death in vitro
Peake, K., Campenot, R. B., Vance, D. E., & Vance, J. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.003 · Cited by 24
Vijayaraghavan, S., Maetzler, W., Reimold, M., Lithner, C. U., Liepelt‐Scarfone, I., Berg, D., & Darreh‐Shori, T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.03.010 · Cited by 24
Plasmin Deficiency in Alzheimer’s Disease Brains: Causal or Casual?
Dotti, C. G., Galván, C. A., & Ledesma, M. D. (2004) · Neurodegenerative Diseases · doi:10.1159/000080987 · Cited by 24
Neurointegrity and europhysiology: astrocyte, glutamate, and carbon monoxide interactions
Mahan, V. L. (2019) · Medical Gas Research · doi:10.4103/2045-9912.254639 · Cited by 24
Cholesterol and Amyloid β Fibrillogenesis
Yanagisawa, K. (2005) · Springer eBooks · doi:10.1007/0-387-23226-5_9 · Cited by 24
Self-citationStaurenghi, E., Leoni, V., Lo Iacono, M., Sottero, B., Testa, G., Giannelli, S., Leonarduzzi, G., & Gamba, P. (2022) · Antioxidants · doi:10.3390/antiox11112168 · Cited by 24
Islam, S., Sun, Y., Gao, Y., Nakamura, T., Noorani, A. A., Li, T., Wong, P. C., Kimura, N., Matsubara, E., Kasuga, K., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2039-21.2021 · Cited by 23
Self-citationAPOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk
Combarros, O., Rodríguez‐Rodríguez, E., Mateo, I., Vázquez‐Higuera, J. L., Infante, J., Berciano, J., & Sánchez‐Juan, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.004 · Cited by 24
Oligomerization of amyloid ?-protein occurs during the isolation of lipid rafts
Yu, W., Zou, K., Gong, J.-S., Ko, M.-H., Yanagisawa, K., & Michikawa, M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20428 · Cited by 24
Self-citationBadea, A., Delpratt, N. A., Anderson, R. J., Dibb, R., Qi, Y. P., Wei, H., Liu, C., Wetsel, W. C., Avants, B., & Colton, C. A. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.03.022 · Cited by 23
Vila‐Rodriguez, F. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090116 · Cited by 22
Straková, J., Demizieux, L., Campenot, R. B., Vance, D. E., & Vance, J. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.017 · Cited by 21
Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells
Rellin, L., Heeren, J., & Beisiegel†, U. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.02.001 · Cited by 21
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 22
Mole, J. P., Fasano, F., Evans, J., Sims, R., Hamilton, D. A., Kidd, E., & Metzler-Baddeley, C. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.014 · Cited by 20
Zhang, A., Zhao, Q., Xu, D., & Jiang, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26398-1 · Cited by 20
Apolipoprotein E4 as a Target for Developing New Therapeutics for Alzheimer's Disease
Refolo, L. M., & Fillit, H. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:151 · Cited by 20
Apolipoprotein E in Temporal Lobe Epilepsy: A Case‐Control Study
Kumar, A., Tripathi, M., Pandey, R. M., Ramakrishnan, L., Srinivas, M., & Luthra, K. (2006) · Disease Markers · doi:10.1155/2006/951632 · Cited by 19
Lipoproteins produced by ApoE–/– astrocytes infected with adenovirus expressing human ApoE
Peng, D., Song, C., Reardon, C. A., Liao, S., & Getz, G. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01950.x · Cited by 19
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Boder, E. J., & Banerjee, I. A. (2021) · Bioengineering · doi:10.3390/bioengineering8120211 · Cited by 18
Increased Vulnerability to Focal Ischemic Brain Injury in Human Apolipoprotein E4 Knock-In Mice
Mori, T., Kobayashi, M., Town, T., Fujita, S. C., & Asano, T. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.3.280 · Cited by 18
Self-citationIurescia, S., Fioretti, D. P., Mangialasche, F., & Rinaldi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100009 · Cited by 18
Huang, Z., Maeda, N., & Mazzone, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017160 · Cited by 16
Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population
Liu, H., Mao, P., Xie, C., Xie, W., Wang, M., & Jiang, H. (2016) · BMC Neurology · doi:10.1186/s12883-016-0537-z · Cited by 16
APOE-ε4-related differences in left thalamic microstructure in cognitively healthy adults
Mole, J. P., Fasano, F., Evans, J., Sims, R., Kidd, E., Aggleton, J. P., & Metzler-Baddeley, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75992-9 · Cited by 15
Allende, L. G., Natalí, L., Cragnolini, A. B., Bollo, M., Musri, M. M., de Mendoza, D., & Martín, M. G. (2024) · Glia · doi:10.1002/glia.24580 · Cited by 18
Brain cholesterol in normal and pathological aging
Vanmierlo, T., Lütjohann, D., & Mulder, M. T. (2011) · Oléagineux Corps gras Lipides · doi:10.1051/ocl.2011.0398 · Cited by 15
Petty, H. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00032 · Cited by 15
Redox status of serum apolipoprotein E and its impact on HDL cholesterol levels
Yamauchi, K., Ebihara, Y., & Kawakami, Y. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.03.021 · Cited by 13
Waldie, S., Sebastiani, F., Moulin, M., Giudice, R. D., Paracini, N., Roosen-Runge, F., Gerelli, Y., Prévost, S., Voss, J., Darwish, T., et al. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.630152 · Cited by 9
Tagalakis, A. D., Dickson, J. G., Owen, J. S., & Simons, J. P. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:1:095 · Cited by 13
Huang, Z. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221042 · Cited by 12
Zhang, R., Wang, X., Liu, J., Yang, S., Tang, Z., Shuan-de, L., Peng, Y., Zhang, H., Yang, X., Zhou, Y., et al. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2011.0103 · Cited by 12
N-Myc and SP Regulate Phosphatidylserine Synthase-1 Expression in Brain and Glial Cells
Tasseva, G., Cole, L., & Vance, J. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158709 · Cited by 12
Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes
Herzine, A., Sekkat, G., Kaminski, S., Calcagno, G., Boschi‐Müller, S., Safi, H., Corbier, C., Visvikis‐Siest, S., Claudepierre, T., & Yen, F. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158630 · Cited by 11
The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions
Yamauchi, K., & Kawakami, Y. (2020) · Biological Chemistry · doi:10.1515/hsz-2019-0414 · Cited by 10
Diaz, J. R., Martá-Ariza, M., Khodadadi‐Jamayran, A., Heguy, A., Tsirigos, A., Pankiewicz, J. E., Sullivan, P. M., & Sadowski, M. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845291 · Cited by 11
Abdullah, M., Ruan, Z., Ikezu, S., & Ikezu, T. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.155 · Cited by 9
Association of APOE gene polymorphism with stroke patients from rural Eastern India
Pal, S., Ganaie, H., Biswas, A., Bhattacharya, A. P., Ray, J., & Das, S. (2019) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_45_19 · Cited by 9
Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis
Lee, S., Parekh, T., King, S. M., Reed, B., Chui, H. C., Krauss, R. M., & Yassine, H. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181252 · Cited by 10
Asiamah, E. A., Feng, B., Guo, R., Yaxing, X., Du, X., Liu, X., Zhang, J., Cui, H., & Ma, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230658 · Cited by 8
Phylogeny and expression patterns of two apolipoprotein E genes in the flatfish Senegalese sole
Román-Padilla, J., Rodriguez‐Rúa, A., Carballo, C., Manchado, M., & Hachero‐Cruzado, I. (2017) · Gene · doi:10.1016/j.gene.2017.11.078 · Cited by 8
Yamauchi, K., Iwasaki, S., & Kawakami, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20190184 · Cited by 7
New APOE-related therapeutic options for Alzheimer’s disease
Li, Z. (2019) · AIP conference proceedings · doi:10.1063/1.5085515 · Cited by 8
Polymorphisms of apolipoprotein E and aneurysmal subarachnoid haemorrhage: A meta-analysis
Arati, S., Sibin, M. K., Bhat, D. I., Narasingarao, K. V. L., & Chetan, G. K. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.06.003 · Cited by 6
Association between Apolipoprotein E Polymorphisms and Epilepsy in Children
Kukuruzović, M. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.04.05 · Cited by 6
Mistry, H., Richardson, C. D., Higginbottom, A., Ashford, B., Ahamed, S. U., Moore, Z., Matthews, F. E., Brayne, C., Simpson, J. E., & Wharton, S. B. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.01.003 · Cited by 6
Garrahy, J. P. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251350338 · Cited by 6
Mouse Models as Tools in Fertility Research and Male-Based Contraceptive Development
Jamsai, D., & O’Bryan, M. K. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-02062-9_10 · Cited by 5
Apolipoprotein E4 inhibits γ‐secretase activity via binding to the γ‐secretase complex
Sun, Y., Islam, S., Gao, Y., Nakamura, T., Zou, K., & Michikawa, M. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15750 · Cited by 5
Self-citationGenetic, Biochemical and Histopathological Aspects of Familiar Alzheimer's Disease
Ortíz, G. G., Pacheco-Moisés, F. P., González-Renovato, E. D., Figuera, L. E., Macías-Islas, M. Á., Mireles-Ramírez, M. A., Flores-Alvarado, L. J., Sánchez-López, A. L., Nuño-Penilla, D. G., Velázquez-Brizuela, I. E., et al. (2015) · InTech eBooks · doi:10.5772/59809 · Cited by 5
Cholesterol—A Janus-Faced Molecule in the Central Nervous System
Wood, W. G., Igbavboa, U., Eckert, G. P., & Müller, W. E. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30380-2_7 · Cited by 5
No association between ApoE polymorphism and febrile seizures
Lavenex, P., Lavenex, P. B., Cachat, F., Gehri, M., & Juvet, T. M. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2351-6 · Cited by 4
Corazzi, L., & Roberti, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_8 · Cited by 4
No association of genetic variants of liver X receptor‐β with alzheimer's disease risk
Rodríguez‐Rodríguez, E., Llorca, J., Mateo, I., Infante, J., Sánchez‐Quintana, C., García‐Gorostiaga, I., Fernández‐Viadero, C., Peña, N., Berciano, J., & Combarros, O. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30652 · Cited by 4
APOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster
Haddadi, M., Haghi, M., Rezaei, N., Kiani, Z., Akkülah, T., & Çelik, A. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105420 · Cited by 4
Akatsu, H., Kamino, K., Yamagata, H. D., Isojima, D., Kondo, I., Yamamoto, T., Kida, T., Takeda, M., Miki, T., & Kosaka, K. (2004) · Psychogeriatrics · doi:10.1111/j.1479-8301.2004.00058.x · Cited by 4
Belyaeva, V. S., Stepenko, Y. V., Lyubimov, I. I., Kulikov, A. L., Tietze, A. A., Kochkarova, I. S., Martynova, O. V., Pokopeyko, O. N., Крупенькина, Л. А., Nagikh, A. S., et al. (2020) · Research Results in Pharmacology · doi:10.3897/rrpharmacology.6.58891 · Cited by 4
Jiang, L., Sun, X., Xie, Y., Dān, W., Xia, Y., & Xu, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135392 · Cited by 2
RetractedCholesterol Trafficking in the Brain
Lütjohann, D., Vanmierlo, T., & Mulder, M. T. (2009) · Springer eBooks · doi:10.1007/978-3-642-00300-4_5 · Cited by 2
Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Hedskog, L. (2012) · Figshare · Cited by 2
Gene Therapy for Neurological Disorders
Malviya, R., Singh, A. K., Goyal, P., & Sundram, S. (2024) · Apple Academic Press eBooks · doi:10.1201/9781003494102 · Cited by 1
Wang, L., Qu, L., Sun, H., & Chen, X. (2026) · Neurology India · doi:10.4103/neurol-india.neurol-india-d-24-00649 · Cited by 1
Sambhariya, W. S., Rickman, C. B., D'Amore, P. A., Corradetti, G., Hageman, G. S., Howell, G. R., Marola, O. J., Phatnani, H. P., Philp, N. J., Sinha, D., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101449 · Cited by 1
ApoE lipidation state directs immunometabolic reprogramming of human microglia
Shiferaw, T., Sarkar, S., Baker, K. M., Wooldridge, R., Binfet, H. M., Prozapas, V. N., Ogbu, C. P., Schepmoes, A. A., Attah, I. K., Niemeyer, C. S., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71882 · Cited by 1
Lord, J., & Morgan, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_3 · Cited by 1
Precision Nutrition in Aging and Brain Health
Chen, S. T., & Small, G. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00017-1 · Cited by 1
Wu, C., Zhou, Q., Huang, Y., Yan, F., Yang, Z., He, L., Li, Q., & Li, L. (2024) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.33010 · Cited by 1
Apolipoproteins E and C1 in the brain: role in Alzheimer's disease
Abildayeva, K. (2006) · Research Publications (Maastricht University) · doi:10.26481/dis.20061220ka
Brain sterol metabolism : modulating Alzheimer’s disease
Vanmierlo, T. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100930tv
Manotas, M. R. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76537
Further insights into Alzheimer's disease
Sims, R., Gerrish, A., & Williams, J. H. (2012) · Quality in Ageing and Older Adults · doi:10.1108/14717791211264043
P2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE
Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703
Aronsen, E. (2009) · Duo Research Archive (University of Oslo)
Wood, M., Mouzon, B., Reed, J., Kayihan, G., Ferguson, S., Mathura, V. S., Roses, A. D., MULLAN, M. J., & Crawford, F. (2016)
Siegel, G., & Rajendran, L. (2018) · Matters · doi:10.19185/matters.201803000014
Targeting Astrocytes With Viral Gene Therapy for Alzheimer’s Disease
Rosenthal, Z. P., Kraft, A. W., Czerniewski, L. R., & Lee, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00005-3
Metadata
- Authors
- Gong, J.-S., Kobayashi, M., Hayashi, H., Zou, K., Sawamura, N., Fujita, S. C., Yanagisawa, K., & Michikawa, M.
- Affiliations
- Japan Society for the Promotion of Science (JP)
- Corresponding author
- Michikawa, Makoto
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 277
- Issue
- 33
- Pages
- 29919-29926
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087083058
- Cited by
- 214
- References
- 68
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 10 · 2021: 10 · 2020: 11 · 2019: 13 · 2018: 6 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 9 · 2012: 6
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, APOE isoforms, APOE3, APOE ε4, astrocytes, lipid secretion, clusterin, cholesterol metabolism, Alzheimer's disease
- MeSH terms
- Animals, Apolipoproteins E, Astrocytes, Cells, Cultured, Humans, Protein Isoforms, Lipid Metabolism, Mice, Apolipoprotein E3, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
